Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Antiplatelet effects of green tea and a major component discussed in Porto

May 12, 2000

New antiplatelet agents with pyrrolidinone structure described by Boehringer Ingelheim

May 12, 2000

Investigational anticoagulant H-376/95/melagatran given wide coverage at recent congress

May 11, 2000

Korean antiplatelet/antithrombotic agent NQ-304 reappears at recent congress

May 10, 2000

Merck describes factor Xa inhibitors and their use in thromboembolic conditions

May 10, 2000

Pamiteplase, a novel t-PA, offers possibility of single bolus injection

May 8, 2000

Selective thrombin inhibitors described in recent patent by Merck researchers

May 4, 2000

In vivo pharmacological profile of antiplatelet agent CS-747

May 3, 2000

New gpIIb/IIIa inhibitor for i.v. administration with sustained pharmacodynamic effects

May 2, 2000

Preliminary clinical data confirm positive effect of oral heparin dosage form

April 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Sun Pharma to acquire Merck spinoff Organon for $11.75B
BioWorld
Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of...